Received May 27, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
Sickness; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of sickness in a male patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced sickness (Verbatim: Sickness). The outcome of the sickness was resolved. The reporter considered the sickness to be related to Shingrix. The company considered the sickness to be related to Shingrix. Additional Information: GSK Receipt Date: 15-MAY-2026 This case was reported by patient via interactive digital media. The patient stated that the vaccine made him sick for a couple of days, but it was worth it. The batch number was not provided, and we are unable to contact the reporter.